Subtopic Deep Dive
Adverse Drug Events Elderly
Research Guide
What is Adverse Drug Events Elderly?
Adverse drug events in the elderly refer to unintended harmful responses to medications in patients aged 65 and older, often linked to polypharmacy, physiological changes, and inappropriate prescribing.
Epidemiological studies quantify ADR incidence at 6.5% of hospital admissions (Pirmohamed et al., 2004, 3166 citations). Frameworks like STOPP/START criteria identify potentially inappropriate medications in seniors (O’Mahony et al., 2014, 2310 citations). Polypharmacy definitions vary but consistently associate multiple drugs with elevated risks (Masnoon et al., 2017, 3035 citations).
Why It Matters
ADRs cause 6.5% of UK hospital admissions, with 72% deemed preventable, driving costs exceeding £466 million annually (Pirmohamed et al., 2004). STOPP/START tools reduce inappropriate prescribing by 33% in trials, informing national guidelines (O’Mahony et al., 2014). Interventions targeting polypharmacy lower hospitalization rates by 20-36%, as shown in systematic reviews (Patterson et al., 2014). CPOE systems with CDS cut serious medication errors by 55%, scalable to geriatric care (Kuperman et al., 2006).
Key Research Challenges
Quantifying Preventability
Distinguishing preventable from non-preventable ADRs requires causality tools like Naranjo algorithm, but prospective data remains limited. Pirmohamed et al. (2004) found 72% preventability in 18,820 admissions, yet hospital-based studies undercount community events. Davies et al. (2009) reported 14.9% ADR incidence in 3695 inpatients.
Standardizing Polypharmacy
Over 50 definitions exist for polypharmacy, complicating risk assessment across studies. Masnoon et al. (2017) reviewed 110 studies, finding no consensus threshold. Guthrie et al. (2015) tracked rising drug-drug interactions in Scotland from 1995-2010.
Implementing Deprescribing
Reducing inappropriate polypharmacy faces clinician resistance despite evidence. Scott et al. (2015) outlined strategies showing 36% ADR reduction. Patterson et al. (2014) Cochrane review found modest benefits from prescription reviews in 32 trials.
Essential Papers
Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients
Munir Pirmohamed, Sally James, Shaun Meakin et al. · 2004 · BMJ · 3.2K citations
Abstract Objective To ascertain the current burden of adverse drug reactions (ADRs) through a prospective analysis of all admissions to hospital. Design Prospective observational study. Setting Two...
What is polypharmacy? A systematic review of definitions
Nashwa Masnoon, Sepehr Shakib, Lisa Kalisch Ellett et al. · 2017 · BMC Geriatrics · 3.0K citations
STOPP/START criteria for potentially inappropriate prescribing in older people: version 2
Denis O’Mahony, David O’Sullivan, Stephen Byrne et al. · 2014 · Age and Ageing · 2.3K citations
Abstract Purpose: screening tool of older people's prescriptions (STOPP) and screening tool to alert to right treatment (START) criteria were first published in 2008. Due to an expanding therapeuti...
Reducing Inappropriate Polypharmacy
Ian Scott, Sarah N. Hilmer, Emily Reeve et al. · 2015 · JAMA Internal Medicine · 1.4K citations
Inappropriate polypharmacy, especially in older people, imposes a substantial burden of adverse drug events, ill health, disability, hospitalization, and even death. The single most important predi...
Understanding Patients’ Adherence-Related Beliefs about Medicines Prescribed for Long-Term Conditions: A Meta-Analytic Review of the Necessity-Concerns Framework
Rob Horne, Sarah Chapman, Rhian Parham et al. · 2013 · PLoS ONE · 1.1K citations
The Necessity-Concerns Framework is a useful conceptual model for understanding patients' perspectives on prescribed medicines. Taking account of patients' necessity beliefs and concerns could enha...
The rising tide of polypharmacy and drug-drug interactions: population database analysis 1995–2010
Bruce Guthrie, Boikanyo Makubate, Virginia Hernandez Santiago et al. · 2015 · BMC Medicine · 787 citations
Drug regimens are increasingly complex and potentially harmful, and people with polypharmacy need regular review and prescribing optimisation. Research is needed to better understand the impact of ...
Medication-related Clinical Decision Support in Computerized Provider Order Entry Systems: A Review
Gilad J. Kuperman, Andrew J. Bobb, Thomas H. Payne et al. · 2006 · Journal of the American Medical Informatics Association · 765 citations
While medications can improve patients' health, the process of prescribing them is complex and error prone, and medication errors cause many preventable injuries. Computer provider order entry (CPO...
Reading Guide
Foundational Papers
Start with Pirmohamed et al. (2004) for ADR epidemiology baseline (3166 citations), then O’Mahony et al. (2014) STOPP/START v2 for screening tools, followed by Kuperman et al. (2006) on CPOE interventions.
Recent Advances
Prioritize Masnoon et al. (2017) polypharmacy review, Scott et al. (2015) deprescribing strategies, Guthrie et al. (2015) drug interaction trends.
Core Methods
Prospective observational studies (Pirmohamed 2004); explicit criteria like STOPP/START (O’Mahony 2014); Necessity-Concerns Framework for adherence (Horne 2013); Cochrane interventions meta-analysis (Patterson 2014).
How PapersFlow Helps You Research Adverse Drug Events Elderly
Discover & Search
Research Agent uses searchPapers('adverse drug events elderly polypharmacy') to retrieve Pirmohamed et al. (2004, 3166 citations), then citationGraph reveals forward citations like O’Mahony et al. (2014). findSimilarPapers on STOPP/START criteria uncovers Masnoon et al. (2017) polypharmacy review. exaSearch drills into geriatric ADR epidemiology across 250M+ OpenAlex papers.
Analyze & Verify
Analysis Agent applies readPaperContent to extract ADR incidence rates from Pirmohamed et al. (2004), then verifyResponse with CoVe cross-checks preventability claims against Davies et al. (2009). runPythonAnalysis computes meta-analytic risk ratios from extracted data using pandas on polypharmacy studies. GRADE grading assesses O’Mahony et al. (2014) STOPP/START evidence as high-quality for intervention design.
Synthesize & Write
Synthesis Agent detects gaps in deprescribing trials post-Patterson et al. (2014), flagging needs for long-term outcomes. Writing Agent uses latexEditText to draft systematic review sections, latexSyncCitations integrates Pirmohamed (2004) bibliography, and latexCompile generates camera-ready manuscript. exportMermaid visualizes ADR causality pathways from Naranjo-linked papers.
Use Cases
"Meta-analyze ADR hospitalization rates from Pirmohamed 2004 and similar elderly studies"
Research Agent → searchPapers → Analysis Agent → runPythonAnalysis (pandas meta-analysis of incidence rates, forest plot) → outputs CSV of pooled RR=6.5% with 95% CI.
"Draft LaTeX review on STOPP/START impact in geriatric polypharmacy"
Synthesis Agent → gap detection on O’Mahony 2014 → Writing Agent → latexEditText + latexSyncCitations (12 papers) + latexCompile → outputs PDF manuscript with tables.
"Find open-source tools for ADR prediction in elderly polypharmacy datasets"
Research Agent → paperExtractUrls on Scott 2015 → Code Discovery → paperFindGithubRepo → githubRepoInspect → outputs validated deprescribing simulation code.
Automated Workflows
Deep Research workflow conducts systematic review: searchPapers(50+ elderly ADR papers) → citationGraph clustering → GRADE assessment → structured report with Pirmohamed (2004) as anchor. DeepScan applies 7-step analysis to polypharmacy interventions: readPaperContent (Patterson 2014) → CoVe verification → runPythonAnalysis on trial data → checkpoint-validated synthesis. Theorizer generates deprescribing hypotheses from Guthrie (2015) trends and Horne (2013) adherence framework.
Frequently Asked Questions
What defines an adverse drug event in the elderly?
Unintended harmful response to medication in patients ≥65 years, including ADRs causing 6.5% hospital admissions (Pirmohamed et al., 2004).
What are key methods for identifying inappropriate prescribing?
STOPP/START criteria screen for 80+ high-risk drugs/interactions in older adults (O’Mahony et al., 2014). Naranjo algorithm assesses ADR causality probabilistically.
What are landmark papers?
Pirmohamed et al. (2004, 3166 citations) quantified ADR admissions; O’Mahony et al. (2014, 2310 citations) updated STOPP/START; Masnoon et al. (2017, 3035 citations) systematized polypharmacy definitions.
What open problems persist?
Limited community-level ADR surveillance beyond hospitals; inconsistent polypharmacy metrics; weak long-term deprescribing trial outcomes (Patterson et al., 2014).
Research Pharmaceutical Practices and Patient Outcomes with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Adverse Drug Events Elderly with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers